Home/Filings/4/0001847903-25-000024
4//SEC Filing

Weinhoff Gregory M 4

Accession 0001847903-25-000024

CIK 0001847903other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:55 PM ET

Size

7.4 KB

Accession

0001847903-25-000024

Insider Transaction Report

Form 4
Period: 2025-02-01
Weinhoff Gregory M
Chief Business Officer
Transactions
  • Award

    Share Option (right to buy)

    2025-02-03+100,000100,000 total
    Exercise: $16.90Exp: 2035-02-03Ordinary Shares (100,000 underlying)
  • Tax Payment

    Ordinary Shares

    2025-02-01$16.92/sh14,267$241,398145,515 total
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
  • [F3]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001400975

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:55 PM ET
Size
7.4 KB